TITLE

Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia

PUB. DATE
January 2009
SOURCE
BMC Psychiatry;2009, Vol. 9, p54
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
45197226

 

Related Articles

  • Predictors of antipsychotic medication change. Sernyak, Michael J.; Leslie, Douglas; Rosenheck, Robert // Journal of Behavioral Health Services & Research;Jan-Mar2005, Vol. 32 Issue 1, p85 

    Atypical antipsychotics account for more than 60% of antipsychotic prescriptions written for the treatment of schizophrenia. While switching from one antipsychotic to another is a dynamic process, there has been no research on individual patient and institutional characteristics that predict...

  • Atypical antipsychotics for schizophrenia: Their collective role and comparative profiles. Kennedy, Annette // Formulary;Jul2001, Vol. 36 Issue 7, p500 

    Focuses on the effect of atypical antipsychotic pharmacotherapy for schizophrenia treatment. Clinical features of schizophrenia; Mechanisms of actions; Effectiveness of Clozapine in treating refractory schizophrenia; Dosage and acquisition costs for atypical antipsychotics.

  • Strategies for Early Non-response to Antipsychotic Drugs in the Treatment of Acute-phase Schizophrenia. Kotaro Hatta; Hiroto Ito // Clinical Psychopharmacology & Neuroscience;Apr2014, Vol. 12 Issue 1, p1 

    As a strategy for antipsychotic treatment of schizophrenia, monotherapy is clearly optimal when both effective and tolerated. When a patient fails to respond to an adequate dose of an antipsychotic, alternatives include switching, administering a higher dose (above the licensed dose),...

  • Pharmacogenomics and schizophrenia: clinical implications. Malhotra, A. K. // Pharmacogenomics Journal;2001, Vol. 1 Issue 2, p109 

    Discusses the clinical implications of the pharmacological treatment of schizophrenia. Disadvantages of using anti-psychotic drugs; Information on pharmacogenetic studies of anti-psychotic drugs; Applications of pharmacogenetic techniques in schizophrenia.

  • Antipsychotic Combination Therapy: Does It Make Sense? Marks, Robert // Behavioral Health Management;Nov/Dec2003, Vol. 23 Issue 6, pS3 

    Ponders on the effectiveness of antipsychotic combination therapy for the treatment of schizophrenia. Medications involved in the practice of such therapy; Practical indications that suggest the merit of such practice; Theoretical bases for combining antipsychotics and conducting clinical...

  • Novel antipsychotic drugs in the management of schizophrenia. Ross, Brendan S.; Ramsey, Leigh Ann // Drug Topics;5/7/2001, Vol. 145 Issue 9, p75 

    Explores the clinical evidences regarding the novel antipsychotic agents used in treating schizophrenia in the United States. Influence of the adverse effects of the antipsychotic agents on treatment strategies; Mechanism of action of the antipsychotic medications; Administration of the...

  • NICE CG178 Psychosis and Schizophrenia in Adults: Treatment and Management -- an evidence-based guideline? Taylor, Mark; Perera, Udayanga // British Journal of Psychiatry;May2015, Vol. 206 Issue 5, p357 

    The authors discuss a clinical guidance on the treatment and management of psychosis and schizophrenia published by the British National Institute for Health and Care Excellence in 2014. Topics covered include the replacement of the 2009 title 'Schizophrenia' with 'Psychosis and Schizophrenia,'...

  • Pharmacotherapy of treatment-resistant schizophrenia: a clinical perspective. Dold, Markus; Leucht, Stefan // Evidence Based Mental Health;May2014, Vol. 17 Issue 2, p33 

    A significant number of patients with schizophrenia do not respond adequately to an initial antipsychotic trial. As first step within a treatment algorithm for therapy-refractory schizophrenia 'pseudoresistance' should be ruled out (eg, re-evaluation of the diagnosis, comorbidities, compliance...

  • Worsened hypertension control induced by aripiprazole. Norio Yasui-Furukori; Akira Fujii // Neuropsychiatric Disease & Treatment;2013, Vol. 9, p505 

    Aripiprazole is widely used in the treatment of schizophrenia and bipolar disorders. Although antipsychotics generally have hypotensive effects, two cases were identified that demonstrated hypertension during the switch from other antipsychotics to aripiprazole. The hypertensive state of these...

  • Åžizofreni Tedavisinde Çoklu Ä°laç Kullanımının Nedenleri. Özalmete, Özlem Albayrak; Özalmete, E. Onur; Ceylan, M. Emin; Sevim, Meltem Efe // Klinik Psikofarmakoloji Bulteni;Mar2009, Vol. 19 Issue 1, p68 

    Recently, the increase of antipsychotic polypharmacy in the treatment of schizophrenia is noticeable. According to the treatment algorithms, monotherapy at adequate dose and for adequate duration should be tried before the use of antipsychotic combinations. It was reported that polypharmacy...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics